Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
British Journal of Cancer
|
April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
A J Watson, M R Middleton, G McGown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
E M Hersh, M Del Vecchio, M P Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B Lee, L Lipton, J Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, R J Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2023
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
S H Cass, J W D Tobin, Y D Seo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C N Owen, X Bai, T Quah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
British Journal of Cancer
|
April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
A J Watson, M R Middleton, G McGown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
E M Hersh, M Del Vecchio, M P Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B Lee, L Lipton, J Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, R J Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2023
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
S H Cass, J W D Tobin, Y D Seo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C N Owen, X Bai, T Quah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Page
of 7